Histopathological indicators, including desmoplastic reaction (DR) and tumour budding (TB), are significant prognostic indicators for metastatic liver lesions in patients with colorectal cancer (CRC). However, the relationship of DR and TB in primary CRC and metastatic lung lesions and their prognostic significance has not yet been examined. This study aimed to elucidate the association of DR and TB in primary CRC and metastatic lung lesions. Patients with pT3 or pT4 CRC with lung metastasis who underwent surgical resection of the primary CRC and synchronous or metachronous metastatic lung lesions were enrolled. DR was classified into immature (IM) and non-IM types, and TB was classified into TB1 (<4 buds), TB2 (5-9 buds) and TB3 (≥10 buds) in both the primary CRC and metastatic lung lesions. Overall, 40 patients with CRC (males, 21; females, 19; median age, 70 years; right-side colon, 6; left-side colon, 9; rectum, 25; pT3, 31; pT4, 9) were evaluated. Six and thirty-four patients were classified as having IM and non-IM DR in the metastatic lung lesions, respectively. Thirty-one, seven, and two patients were classified as having TB1, TB2, and TB3, respectively. There was no significant correlation between primary and lung metastatic lesions for DR ( = 0.08, = 0.086), whereas TB demonstrated a moderate correlation ( = 0.47, = 0.015). The presence of IM DR and TB2/3 in metastatic lung lesions significantly correlated with poor overall survival ( = 0.0020 and 0.044, respectively). histological indicators of metastatic lung lesions in CRC may provide important prognostic information for better patient care.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11852406 | PMC |
http://dx.doi.org/10.3390/cancers17040583 | DOI Listing |
Cancer Manag Res
March 2025
Department of internal medicine, King Hussein Cancer Center, Amman, Jordan.
Background And Aim: Ovarian metastasis occurs in 3-5% of patients with CRC. Ovaries are considered sanctuary sites and typically do not respond effectively to chemotherapy. Patients with KRAS mutation generally have a worse prognosis compared to those with KRAS wild type.
View Article and Find Full Text PDFRev Neurol (Paris)
March 2025
Centre Hospitalier Universitaire de Nice, Service de Neurologie, CRC SEP, Nice, France; Université Nice Côte d'Azur, UR2CA-URRIS, Nice, France.
Work difficulties are a primary issue of multiple sclerosis (MS). This is because disease onset usually occurs during a time when establishing a career and employment is of paramount importance. The MSWDQ-23 (Multiple Sclerosis Work Difficulties Questionnaire) was developed to assess work difficulties in MS.
View Article and Find Full Text PDFSci Rep
March 2025
Department of Oncology and Hematology, Xijing 986 Hospital, No. 269 Youyi East Road, Beilin District, Xi'an, 710054, Shaanxi, China.
Buzhong Yiqi Decoction (BZYQD) is a traditional Chinese medicine renowned for its anti-colorectal cancer (CRC) properties. However, the bioactive components and mechanisms of BZYQD against CRC remain unknown. In this study, LC-MS was used to analyze the chemical composition of BZYQD.
View Article and Find Full Text PDFCrit Rev Oncol Hematol
March 2025
Division of Gastroenterology, Fondazione IRCCS - Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy. Electronic address:
Colorectal cancer (CRC) is the third most common and second most deadly cancer worldwide. Despite advances in screening and treatment, CRC is heterogeneous and the response to therapy varies significantly, limiting personalized treatment options. Certain molecular biomarkers, including microsatellite instability (MSI), are critical in planning personalized treatment, although only a subset of patients may benefit.
View Article and Find Full Text PDFJAMA
March 2025
CHU Nimes, Service de Neurologie, Univ Montpellier, Nimes, France.
Importance: Vitamin D deficiency is a risk factor for multiple sclerosis (MS) and is associated with the risk of disease activity, but data on the benefits of supplementation are conflicting.
Objective: To evaluate the efficacy of high-dose cholecalciferol as monotherapy in reducing disease activity in patients with clinically isolated syndrome (CIS) typical for MS.
Design, Setting, And Participants: The D-Lay MS trial was a parallel, double-blind, randomized placebo-controlled clinical trial in 36 MS centers in France.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!